IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Discover Oncology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

2.29

h-Index

2022-2023

 42

Rank

2022-2023

 10076

SJR

2022-2023

 0.514

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Discover Oncology
Abbreviation Discov. Oncol.
Publication Type Journal
Subject Area, Categories, Scope Endocrinology (Q3); Endocrinology, Diabetes and Metabolism (Q3); Oncology (Q3); Cancer Research (Q4); Endocrine and Autonomic Systems (Q4)
h-index 42
Overall Rank/Ranking 10076
SCImago Journal Rank (SJR) 0.514
Impact Score 2.29
Publisher Springer Science and Business Media Deutschland GmbH
Country Germany
ISSN 27306011
Best Quartile Q3
Coverage History 2021-2022




About Discover Oncology


Discover Oncology is a journal covering the technologies/fields/categories related to Endocrinology (Q3); Endocrinology, Diabetes and Metabolism (Q3); Oncology (Q3); Cancer Research (Q4); Endocrine and Autonomic Systems (Q4). It is published by Springer Science and Business Media Deutschland GmbH. The overall rank of Discover Oncology is 10076. According to SCImago Journal Rank (SJR), this journal is ranked 0.514. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 42. The best quartile for this journal is Q3.

The ISSN of Discover Oncology journal is 27306011. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Discover Oncology is cited by a total of 278 articles during the last 3 years (Preceding 2022).


Discover Oncology Impact IF 2022-2023


The Impact IF 2022 of Discover Oncology is 2.29, which is computed in 2023 as per its definition. Discover Oncology IF is decreased by a factor of 2.3 and approximate percentage change is -50.11% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Discover Oncology Impact IF 2023 Prediction


Impact IF 2022 of Discover Oncology is 2.29. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Discover Oncology. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 2.29
2021 4.59
2020 3.63
2019 2.44
2018 2.35
2017 2.41
2016 3.20
2015 3.27
2014 3.00

Discover Oncology h-index


  Table Setting

Discover Oncology has an h-index of 42. It means 42 articles of this journal have more than 42 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Discover Oncology ISSN


The ISSN of Discover Oncology is 27306011. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Discover Oncology Rank and SCImago Journal Rank (SJR)


The overall rank of Discover Oncology is 10076. According to SCImago Journal Rank (SJR), this journal is ranked 0.514. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Discover Oncology by Year


Year SJR
2023/2024 Coming Soon
2022 0.514
2021
2020
2019
2018
2017
2016
2015
2014

Ranking of Discover Oncology by Year


Year Ranking
2023/2024 Coming Soon
2022 10076
2021 27207
2020 33141
2019 30735
2018 32182
2017 32937
2016 32662
2015 32314
2014 31708

Discover Oncology Publisher


Table Setting

Discover Oncology is published by Springer Science and Business Media Deutschland GmbH. It's publishing house is located in Germany. Coverage history of this journal is as following: 2021-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Discover Oncology is Discov. Oncol.. This abbreviation ('Discov. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Discover Oncology


If your research field is/are related to Endocrinology (Q3); Endocrinology, Diabetes and Metabolism (Q3); Oncology (Q3); Cancer Research (Q4); Endocrine and Autonomic Systems (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Discover Oncology?

Discover Oncology latest impact IF is 2.29. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 4.59 (2021) and 2.29 (2022), respectively, in the last 9 years. Moreover, its average IS is 3.02 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Discover Oncology?

The Discover Oncology has an SJR (SCImago Journal Rank) of 0.514, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.514 in 2022 and the lowest being in 2021. Furthermore, the average SJR of the Discover Oncology over the previous 9-year period stands at 3.02.


What's the latest h-index of the Discover Oncology?

The latest h-index of the Discover Oncology is 42.


Who's the publisher of the Discover Oncology?

The Discover Oncology is published by the Springer Science and Business Media Deutschland GmbH, with its country of publication being the Germany.


What's the current ranking of the Discover Oncology?

The Discover Oncology is currently ranked 10076 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 10076 in 2022 and its lowest position of 33141 in 2020.


What's the abbreviation or short name for the Discover Oncology?

The standard ISO4 abbreviation for the Discover Oncology is Discov. Oncol..


Is the "Discover Oncology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Discover Oncology is classified as a journal that the Springer Science and Business Media Deutschland GmbH publishes.


What's the scope or major areas of the Discover Oncology?

The Discover Oncology encompasses the following areas:

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Cancer Research
  • Endocrine and Autonomic Systems

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Discover Oncology?

The Discover Oncology is assigned the following International Standard Serial Numbers (ISSN): 27306011.


What's the best quartile of the Discover Oncology?

The best quartile for the Discover Oncology is Q3 (2022).


What's the coverage history of the Discover Oncology?

The Discover Oncology coverage history can be summarized as follows: 2021-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Business: Theory and Practice journal 13414 Vilnius Gediminas Technical University 21 2.47
Journal of Field Archaeology journal 5639 Maney Publishing 43 2.38
Revue Francophone des Laboratoires (discontinued) journal 23244 Elsevier Masson s.r.l. 8 0.00
Qualitative Research journal 2108 SAGE Publications Ltd 86 3.97
Criminal Justice Review journal 8738 SAGE Publications Inc. 41 1.30
Business Strategy Review journal 31512 Wiley-Blackwell Publishing Ltd 33 0.04
World Englishes journal 4960 Wiley-Blackwell 60 1.97
Marine Biology Research journal 13573 Taylor and Francis Ltd. 42 1.06
Modern Language Journal journal 918 Wiley-Blackwell 103 3.89
Syntax journal 3422 Wiley-Blackwell Publishing Ltd 29 0.93

Check complete list




Year wise Impact Score (IS) of Discover Oncology

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.29
2021 4.59
2020 3.63
2019 2.44
2018 2.35
2017 2.41
2016 3.20
2015 3.27
2014 3.00



Top Journals/Conferences in Endocrinology

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Endocrine Reviews
The Endocrine Society | United States

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Diabetologia
Springer Verlag | Germany

Metabolism: Clinical and Experimental
W.B. Saunders Ltd | United Kingdom

Obesity Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Diabetes
American Diabetes Association Inc. | United States

Cytokine and Growth Factor Reviews
Elsevier BV | United Kingdom

See All

Top Journals/Conferences in Endocrinology, Diabetes and Metabolism

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Endocrine Reviews
The Endocrine Society | United States

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Diabetologia
Springer Verlag | Germany

Metabolism: Clinical and Experimental
W.B. Saunders Ltd | United Kingdom

Obesity Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Diabetes
American Diabetes Association Inc. | United States

Cytokine and Growth Factor Reviews
Elsevier BV | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Endocrine and Autonomic Systems

Brain, Behavior, and Immunity
Academic Press Inc. | United States

Frontiers in Neuroendocrinology
Academic Press Inc. | United States

Neurobiology of Stress
Elsevier BV | Netherlands

Neurogastroenterology and Motility
Wiley-Blackwell Publishing Ltd | United Kingdom

Psychoneuroendocrinology
Elsevier Ltd. | United Kingdom

Psychophysiology
Wiley-Blackwell Publishing Ltd | United Kingdom

Clinical Autonomic Research
D. Steinkopff-Verlag | Germany

Hormones and Behavior
Academic Press Inc. | United States

Neuroendocrinology
S. Karger AG | Switzerland

Journal of Neuroendocrinology
Wiley-Blackwell Publishing Ltd | United Kingdom

See All